{"id":"W2800761096","doi":"10.1093/rheumatology/kez107.077","title":"261 Secukinumab 150 mg provides sustained improvements in the signs and symptoms of active ankylosing spondylitis with high retention rate: 4-year results from the Phase 3 trial, MEASURE 2","year":2019,"lang":"en","type":"article","venue":"Lara D. Veeken","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Secukinumab; Ankylosing spondylitis; Measure (data warehouse); Physical therapy; Internal medicine; Arthritis; Psoriatic arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001473003,0.0008058298,0.0010798,0.0002148986,0.0002353143,0.000734688,0.0003911934,0.0005571268,0.002456263],"category_scores_gemma":[0.0006335573,0.0002586613,0.001083637,0.0001997693,0.0004562665,0.0004256307,0.0001948869,0.001273526,0.0005677133],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003630112,"about_ca_system_score_gemma":0.0004865201,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003444615,"about_ca_topic_score_gemma":0.001014891,"domain_scores_codex":[0.9996701,0.0001585637,0.00002563973,0.0000378832,0.00005523071,0.00005259949],"domain_scores_gemma":[0.9995996,0.00007432963,0.000145493,0.00002705896,0.00003514899,0.0001183832],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8326892,0.01976679,0.007210193,0.001649591,0.001888357,0.000282145,0.0002163661,0.001014413,0.04983773,0.0001901345,0.004022679,0.08123245],"study_design_scores_gemma":[0.4084845,0.5550649,0.02598452,0.00008824441,0.0008090025,0.0004114138,0.00005620894,0.0007638028,0.005855872,0.00008748182,0.002356244,0.0000378004],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955977,0.002455889,0.0001781573,0.0001502394,0.00006850574,0.0003429939,0.000402403,0.00005229695,0.0007518741],"genre_scores_gemma":[0.9948198,0.001513219,0.0004523391,0.0003432097,0.0001117297,0.0004335011,0.0009365781,0.00001395341,0.001375616],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002456263,"threshold_uncertainty_score":0.008217096,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0149780079997249,"score_gpt":0.2572736978692318,"score_spread":0.2422956898695069,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}